Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
The Pharma Letter
46m
Erleada shows clinically-meaningful improvement in prostate cancer OS
Johnson & Johnson today released results of a landmark real-world head-to-head study showing that Erleada (apalutamide) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court filing made public
Helene's wake
Walz, Vance VP debate
Teacher wins pronouns case
MS-13 associate sentenced
Suspended five games
NASCAR sued by Jordan
Repairman's claims rejected
Factory probed after Helene
Starlink terminals to NC
Sex offender registry ruling
AZ voter registration glitch
Historic ship reef plan
Labor board targets Apple
Israel sends more troops
Drop box ban lawsuit
Blasts near Israeli Embassy
CO2 found on Pluto's moon
CA food chemicals ban
Michel sues Hill for fraud
AG appeals abortion ruling
1K troops to aid NC
Nintendo opens museum
Man sentenced for cloning
AR marijuana expansion suit
November trial set
GA disaster declaration
Valuation reaches $157B
Related topics
Zydus
Erleada
Johnson & Johnson
Food and Drug Administration
USFDA
Feedback